Novel functions of the alpha-ketoglutarate dehydrogenase complex may mediate diverse oxidant-induced changes in mitochondrial enzymes associated with Alzheimer's disease.

Biochimica Et Biophysica Acta
Qingli ShiG E Gibson

Abstract

Measures in autopsied brains from Alzheimer's Disease (AD) patients reveal a decrease in the activity of alpha-ketoglutarate dehydrogenase complex (KGDHC) and an increase in malate dehydrogenase (MDH) activity. The present experiments tested whether both changes could be caused by the common oxidant H(2)O(2) and to probe the mechanism underlying these changes. Since the response to H(2)O(2) is modified by the level of the E2k subunit of KGDHC, the interaction of MDH and KGDHC was studied in cells with varying levels of E2k. In cells with only 23% of normal E2k protein levels, one-hour treatment with H(2)O(2) decreased KGDHC and increased MDH activity as well as the mRNA level for both cytosolic and mitochondrial MDH. The increase in MDH did not occur in cells with 100% or 46% of normal E2k. Longer treatments with H(2)O(2) inhibited the activity of both enzymes. Glutathione is a major regulator of cellular redox state and can modify enzyme activities. H(2)O(2) converts reduced glutathione (GSH) to oxidized glutathione (GSSG), which reacts with protein thiols. Treatment of purified KGDHC with GSSG leads to glutathionylation of all three KGDHC subunits. Thus, cellular glutathione level was manipulated by two means to determine the...Continue Reading

References

May 19, 1975·Biochemical and Biophysical Research Communications·M Foster, J H Harrison
Aug 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·L J ReedR M Oliver
Jan 1, 1991·Advances in Experimental Medicine and Biology·S I RapoportM B Schapiro
Dec 1, 1990·Metabolic Brain Disease·R F Butterworth, A M Besnard
Aug 15, 1988·The Biochemical Journal·J B Hoek, J Rydström
Jan 1, 1969·European Journal of Biochemistry·D Dupourque, E Kun
Jan 1, 1984·Methods in Enzymology·H F Gilbert
Nov 1, 1983·Archives of Neurology·D F BensonS Y Tsai
Apr 29, 1983·Science·A Meister
Sep 1, 1994·Neurochemical Research·L Balazs, M Leon
Dec 1, 1993·Journal of Neurochemistry·F MastrogiacomoS J Kish
Jan 1, 1994·The American Journal of Clinical Nutrition·M Toborek, B Hennig
Oct 1, 1993·Alcoholism, Clinical and Experimental Research·R F ButterworthC G Harper
Jan 1, 1996·Free Radical Biology & Medicine·J P BolañosJ B Clark
Jan 1, 1997·Neurobiology of Aging·M J De LeonH M Wisniewski
Mar 12, 1998·Brain Research. Brain Research Reviews·J S Bains, C A Shaw
Jan 8, 1999·Journal of the Neurological Sciences·D TerwelJ Jolles
Feb 16, 1999·Brain Pathology·W R Markesbery, J M Carney
Sep 2, 1999·Neuroscience Letters·F J Jiménez-JiménezC Villanueva
Feb 17, 2000·Neurochemistry International·G E GibsonN Y Calingasan
Jul 6, 2000·Progress in Neurobiology·R Dringen
Jul 19, 2000·Biochimica Et Biophysica Acta·M A SmithG Perry
Aug 10, 2000·European Journal of Biochemistry·R Dringen
Aug 10, 2000·European Journal of Biochemistry·J B SchulzJ Dichgans
Feb 7, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·R De WitJ A Post
Apr 3, 2001·The Journal of Biological Chemistry·A C Nulton-Persson, L I Szweda

❮ Previous
Next ❯

Citations

Sep 9, 2008·Antioxidants & Redox Signaling·John J MieyalMelissa D Shelton
Dec 17, 2009·Antioxidants & Redox Signaling·Amadou K S CamaraDavid F Stowe
Dec 8, 2011·Antioxidants & Redox Signaling·Diane E Handy, Joseph Loscalzo
May 12, 2011·Expert Opinion on Drug Metabolism & Toxicology·Arthur Jl CooperPatrick S Callery
Aug 26, 2009·The International Journal of Biochemistry & Cell Biology·José M MatésJavier Márquez
Mar 10, 2015·Biochemistry. Biokhimii︠a︡·E V KalininaM D Novichkova
Apr 14, 2016·The International Journal of Neuroscience·Aslina Pahrudin ArroziSuzana Makpol
Jul 14, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Aleksandra Maruszak, Cezary Żekanowski
Mar 1, 2017·Free Radical Biology & Medicine·Marisa O'BrienRyan J Mailloux
Jul 5, 2018·Organic & Biomolecular Chemistry·Roberta GaleazziTatiana Armeni
Dec 3, 2009·Antioxidants & Redox Signaling·Sergio Rosales-CorralGabriela Lopez-Armas
Apr 22, 2009·Journal of Neuroscience Research·Jeff R LiddellRalf Dringen
Dec 17, 2008·Annals of the New York Academy of Sciences·Gary E GibsonQingli Shi
May 30, 2012·Neuropathology and Applied Neurobiology·G HarishS K Shankar
Aug 15, 2018·Journal of Alzheimer's Disease : JAD·Olga ZolochevskaGiulio Taglialatela
Apr 25, 2019·International Journal of Molecular Sciences·Md Mamunul HaqueJun-Seok Lee
Aug 11, 2020·Analytical Biochemistry·Dunxin ShenTravis T Denton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.